Chad M. Robins - Jun 15, 2021 Form 4 Insider Report for Adaptive Biotechnologies Corp (ADPT)

Role
CEO and Chairman, Director
Signature
/s/ Chad Robins by Eric Billings, Attorney-in-Fact
Stock symbol
ADPT
Transactions as of
Jun 15, 2021
Transactions value $
-$1,153,965
Form type
4
Date filed
6/17/2021, 09:00 PM
Next filing
Jul 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADPT Common Stock Sale -$730K -19.1K -1.09% $38.22* 1.73M Jun 15, 2021 Direct F1, F2
transaction ADPT Common Stock Sale -$35.3K -900 -0.05% $39.23* 1.73M Jun 15, 2021 Direct F1, F3
transaction ADPT Common Stock Sale -$181K -4.75K -0.27% $38.13* 1.72M Jun 16, 2021 Direct F1, F4
transaction ADPT Common Stock Sale -$38.6K -1K -0.06% $38.55* 1.72M Jun 17, 2021 Direct F1, F5
transaction ADPT Common Stock Sale -$169K -4.26K -0.25% $39.76* 1.72M Jun 17, 2021 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 22, 2020.
F2 The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $38.00 to 38.91, inclusive. The reporting person undertakes to provide to Adaptive Biotechnologies Corporation, any security holder of Adaptive Biotechnologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in any footnotes to this Form 4.
F3 The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $39.00 to 39.42, inclusive.
F4 The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $38.00 to 38.46, inclusive.
F5 The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $38.06 to 39.04, inclusive.
F6 The price reported for this transaction is a weighted-average price. The shares were sold in multiple transactions ranging from $39.35 to 40.09, inclusive.